Form 8-K - Current report:
SEC Accession No. 0001140361-21-037932
Filing Date
2021-11-15
Accepted
2021-11-15 17:14:57
Documents
72
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10030844_8k.htm   iXBRL 8-K 34769
2 EXHIBIT 99.1 brhc10030844_ex99-1.htm EX-99.1 174429
3 EXHIBIT 99.2 brhc10030844_ex99-2.htm EX-99.2 129629
7 brhc10030844_ex99-2slide2.jpg GRAPHIC 380661
8 brhc10030844_ex99-2slide3.jpg GRAPHIC 243950
9 brhc10030844_ex99-2slide4.jpg GRAPHIC 208095
10 brhc10030844_ex99-2slide5.jpg GRAPHIC 209441
11 brhc10030844_ex99-2slide6.jpg GRAPHIC 180198
12 brhc10030844_ex99-2slide7.jpg GRAPHIC 134699
13 brhc10030844_ex99-2slide8.jpg GRAPHIC 58956
14 brhc10030844_ex99-2slide9.jpg GRAPHIC 155920
15 brhc10030844_ex99-2slide10.jpg GRAPHIC 149437
16 brhc10030844_ex99-2slide12.jpg GRAPHIC 157738
17 brhc10030844_ex99-2slide13.jpg GRAPHIC 187768
18 brhc10030844_ex99-2slide14.jpg GRAPHIC 195328
19 brhc10030844_ex99-2slide15.jpg GRAPHIC 169428
20 brhc10030844_ex99-2slide16.jpg GRAPHIC 160390
21 brhc10030844_ex99-2slide17.jpg GRAPHIC 175606
22 brhc10030844_ex99-2slide18.jpg GRAPHIC 164072
23 brhc10030844_ex99-2slide19.jpg GRAPHIC 208403
24 brhc10030844_ex99-2slide20.jpg GRAPHIC 187818
25 brhc10030844_ex99-2slide21.jpg GRAPHIC 61324
26 brhc10030844_ex99-2slide22.jpg GRAPHIC 212560
27 brhc10030844_ex99-2slide23.jpg GRAPHIC 175857
28 brhc10030844_ex99-2slide24.jpg GRAPHIC 171823
29 brhc10030844_ex99-2slide25.jpg GRAPHIC 196598
30 brhc10030844_ex99-2slide26.jpg GRAPHIC 197878
31 brhc10030844_ex99-2slide27.jpg GRAPHIC 149917
32 brhc10030844_ex99-2slide28.jpg GRAPHIC 150701
33 brhc10030844_ex99-2slide29.jpg GRAPHIC 161998
34 brhc10030844_ex99-2slide30.jpg GRAPHIC 154552
35 brhc10030844_ex99-2slide31.jpg GRAPHIC 135647
36 brhc10030844_ex99-2slide32.jpg GRAPHIC 129271
37 brhc10030844_ex99-2slide33.jpg GRAPHIC 170410
38 brhc10030844_ex99-2slide34.jpg GRAPHIC 61084
39 brhc10030844_ex99-2slide35.jpg GRAPHIC 178757
40 brhc10030844_ex99-2slide36.jpg GRAPHIC 164809
41 brhc10030844_ex99-2slide37.jpg GRAPHIC 136859
42 brhc10030844_ex99-2slide38.jpg GRAPHIC 148431
43 brhc10030844_ex99-2slide39.jpg GRAPHIC 69015
44 brhc10030844_ex99-2slide40.jpg GRAPHIC 173383
45 brhc10030844_ex99-2slide41.jpg GRAPHIC 186744
46 brhc10030844_ex99-2slide42.jpg GRAPHIC 207126
47 brhc10030844_ex99-2slide43.jpg GRAPHIC 171249
48 brhc10030844_ex99-2slide44.jpg GRAPHIC 173355
49 brhc10030844_ex99-2slide45.jpg GRAPHIC 172666
50 brhc10030844_ex99-2slide46.jpg GRAPHIC 157446
51 brhc10030844_ex99-2slide47.jpg GRAPHIC 154789
52 brhc10030844_ex99-2slide48.jpg GRAPHIC 37268
53 brhc10030844_ex99-2slide49.jpg GRAPHIC 190867
54 brhc10030844_ex99-2slide50.jpg GRAPHIC 171629
55 brhc10030844_ex99-2slide51.jpg GRAPHIC 200013
56 brhc10030844_ex99-2slide52.jpg GRAPHIC 158986
57 brhc10030844_ex99-2slide54.jpg GRAPHIC 89683
58 brhc10030844_ex99-2slide55.jpg GRAPHIC 32006
59 brhc10030844_ex99-2slide57.jpg GRAPHIC 180067
60 brhc10030844_ex99-2slide58.jpg GRAPHIC 83736
61 brhc10030844_ex99-2slide68.jpg GRAPHIC 61001
62 brhc10030844_ex99-2slide110.jpg GRAPHIC 113623
63 brhc10030844_ex99-2slide113.jpg GRAPHIC 144528
64 image0.jpg GRAPHIC 6484
  Complete submission text file 0001140361-21-037932.txt   12952555

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ocup-20211112.xsd EX-101.SCH 3923
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20211112_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20211112_pre.xml EX-101.PRE 16042
65 EXTRACTED XBRL INSTANCE DOCUMENT brhc10030844_8k_htm.xml XML 4077
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 211412423
SIC: 2834 Pharmaceutical Preparations